OncoLink Cancer Treatment and Resources

Measuring the SUV (Standardized Uptake Value) for PET scans

Peeyush Bhargava, MD
Last Modified: October 27, 2002

Question

Dear OncoLink "Ask The Experts,"
I have had three PET scans for my malignant melanoma. My first one was April 2000 to evaluate me for Interferon; it was negative. The second was October 2001 because I had another lymph node swollen. That PET was negative except for that node. My last one June 2002 showed low activity in legs and neck. What is the activity Measuring the SUV (Standardized Uptake Value) level of concern? I heard that the activity is graded 0-20. 

Answer

Peeyush Bhargava, MD, Chief Fellow in the Department of Nuclear Medicine at the University of Pennsylvania, responds:

PET scans are complex studies involving a lot of variables related to the patient and to the technique. The images show the distribution and metabolism of FDG (fluoro-deoxy glucose) throughout the body. Cancers show up as foci/areas of intense activity since cancer cells are more active and take up a lot of FDG.

There can be other causes of intense activity such as inflammation, infection, or muscle activity. Measuring the SUV (Standardized Uptake Value) is a semi?quantitative way to assess the activity in a given focus. It represents the amount of activity in the focus relative to the activity in the other (normal) areas of the body. Typically, the SUV value of metastatic lesion is above 2.5. The pattern of activity (the distribution of lesions in the different parts of the body) is also very important as different cancers have different preferential sites of metastasis. Also, patient's history and findings on other anatomic imaging like CT scans and MRI are taken into consideration while reading the PET scans.
Below are the images from a patient's PET scan (coronal images, anterior to posterior), which show intense activity in the different muscle groups. This patient did not fast long enough before the study was performed. This caused increased FDG uptake in the muscles and can lead to an incorrectly interpreted study.

OncoLink I wish u knew...

Dr. Vapiwala discusses the Affordable Care Act and access to healthcare. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS